FDA Issues Four Guidances Dealing With Clinical Trial Issues

摘要

The FDA released four guidances in the past month dealing with clinical trials, including guidance on the use of blinding in cancer trials and the enrollment of male subjects in breast cancer trials, as well as recommendations for trials dealing with two diseases.